4//SEC Filing
Wolfson Marina 4
Accession 0001213900-23-095420
CIK 0001739174other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:45 PM ET
Size
18.6 KB
Accession
0001213900-23-095420
Insider Transaction Report
Form 4
BiomX Inc.PHGE
Wolfson Marina
Chief Financial Officer
Transactions
- Award
Common Stock Options - Right to Buy
2023-12-11+9,474→ 9,474 totalExercise: $0.27Exp: 2030-03-25→ Common Stock (9,474 underlying) - Disposition to Issuer
Common Stock Options - Right to Buy
2023-12-11−33,250→ 0 totalExercise: $7.02Exp: 2031-03-30→ Common Stock (33,250 underlying) - Award
Common Stock Options - Right to Buy
2023-12-11+8,750→ 8,750 totalExercise: $0.27Exp: 2031-03-30→ Common Stock (8,750 underlying) - Disposition to Issuer
Common Stock Options - Right to Buy
2023-12-11−50,000→ 0 totalExercise: $1.41Exp: 2032-03-29→ Common Stock (50,000 underlying) - Award
Common Stock Options - Right to Buy
2023-12-11+35,715→ 35,715 totalExercise: $0.27Exp: 2032-03-29→ Common Stock (35,715 underlying) - Disposition to Issuer
Common Stock Options - Right to Buy
2023-12-11−36,000→ 0 totalExercise: $6.21Exp: 2030-03-25→ Common Stock (36,000 underlying)
Footnotes (6)
- [F1]On December 11, 2023, the Issuer canceled, pursuant to the Issuer's option exchange program, an option for 36,000 shares of the Issuer's common stock granted to the Reporting Person on March 25, 2020. In exchange, the Reporting Person received a replacement option, for 9,474 shares, having an exercise price of $0.2749 per share.
- [F2]The cancelled option provided for vesting over four years, with 25% of the shares subject to the option vested on March 25, 2021, and the remainder vested in 12 equal quarterly installments over three years. The replacement option vests according to the same vesting schedule applicable to the cancelled option; provided, however, that the replacement option may not be exercised prior to December 11, 2024.
- [F3]On December 11, 2023, the Issuer canceled, pursuant to the Issuer's option exchange program, an option for 33,250 shares of the Issuer's common stock granted to the Reporting Person on March 30, 2021. In exchange, the Reporting Person received a replacement option, for 8,750 shares, having an exercise price of $0.2749 per share.
- [F4]The cancelled option provided for vesting over four years, with 25% of the shares subject to the option vested on March 30, 2022, and the remainder vested in 12 equal quarterly installments over three years. The replacement option vests according to the same vesting schedule applicable to the cancelled option; provided, however, that the replacement option may not be exercised prior to December 11, 2024.
- [F5]On December 11, 2023, the Issuer canceled, pursuant to the Issuer's option exchange program, an option for 50,000 shares of the Issuer's common stock granted to the Reporting Person on March 29, 2022. In exchange, the Reporting Person received a replacement option, for 35,715 shares, having an exercise price of $0.2749 per share.
- [F6]The cancelled option provided for vesting over four years, with 25% of the shares subject to the option vested on March 29, 2023, and the remainder vested in 12 equal quarterly installments over three years. The replacement option vests according to the same vesting schedule applicable to the cancelled option; provided, however, that the replacement option may not be exercised prior to December 11, 2024.
Documents
Issuer
BiomX Inc.
CIK 0001739174
Entity typeother
Related Parties
1- filerCIK 0001797360
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:45 PM ET
- Size
- 18.6 KB